Pediatric Oncology & Hematology continues to advance through innovative research, precision medicine, targeted therapies, and improved supportive care for children with cancer and blood disorders. Early diagnosis and multidisciplinary treatment approaches have significantly increased survival rates while improving quality of life for pediatric patients. This session focuses on the latest scientific developments in childhood cancer and hematological diseases.
Scientific discussions will include leukemia, lymphoma, solid tumors, pediatric anemia, bleeding disorders, bone marrow transplantation, immunotherapy, targeted therapies, survivorship care, and supportive oncology. Participants will also explore clinical trials, molecular diagnostics, and personalized treatment strategies that enhance pediatric cancer care.
This session provides a valuable platform for pediatric oncologists, hematologists, researchers, nurses, laboratory scientists, and healthcare professionals to collaborate, present groundbreaking research, and contribute to improving outcomes for children with cancer and hematological disorders.